Abstract
Head and neck squamous cell carcinoma (HNSCC) is one of the tumors of poor prognosis despite the therapeutic advances in the past few years. It has been reported that overexpression of AT1R occurs in many human carcinomas. However, the molecular mechanisms by which angiotensin II type 1 receptor (AT1R) mediate its invasive effects in HNSCC still unclear. Here, we found that AT1R was not only found in HNSCC specimens, but also significantly correlated with advanced TNM-stage and the poor 5-year survival rate. Thus indicated that AT1R was an independent factor for HNSCC development. Functionally, AT1R could promote tumor growth in nude mice. In addition, AT1R had the abilities to stimulate cell migration and invasion in oral cancer cells through increased FLJ10540 and MCP-1 expression by Transwell chambers. Conversely, depletion of AT1R expression by siRNAs suppressed FLJ10540 and MCP-1 protein expressions. Suppression MCP-1 could cause significant inhibition on cell migratory and invasive ability of AT1R-overexpressing head and neck cancer cells. Finally, immunohistochemical and Western blotting analysis of human aggressive HNSCC specimens showed a significant positively correlation among AT1R, FLJ10540 and MCP-1 expression. These findings suggest that AT1R is not only an important prognostic factor but also a new therapeutic target in the FLJ10540/MCP-1 pathway for HNSCC treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.